Immutep Ltd share price logo

Immutep Ltd Share Price

NASDAQ: IMMP

Small Cap

$1.69

-0.04

(-2.31%)

Live

as on

Immutep Ltd Stock Performance

as on September 16, 2025 at 11:41 pm IST

  • Day's Low

    Day's High

    $1.68
    $1.72
    downward going graph

    0.59%

    Downside

    1.78%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.32
    $2.71
    downward going graph

    21.89%

    Downside

    60.36%

    Upside

    downward going graph

Immutep Ltd share price movements today

Previous Close
$1.73
Open
$1.70
Volume
242.9K
Day's Low - High
$1.68 - $1.72
52 Week Low - High
$1.32 - $2.71

Immutep Ltd Historical Returns

1 Month Return
0 %
3 Month Return
+ 1.17 %
1 Year Return
-25.11 %
3 Year Return
-3.89 %
5 Year Return
+ 8.12 %

Immutep Ltd Stock Fundamentals & Key Indicators

Check Immutep Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$253.9M

EPS (TTM)

-0.2393

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-62.9M

Revenue (TTM)

5.0M

Profit Margin

0.00%

Return On Equity TTM

11640200.00%

Immutep Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immutep Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Immutep Ltd image
Immutep Ltd
BUY$253.9M8.12%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.1B251.26%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$38.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$101.2B47.46%28.0931.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.6B0.6%14.131.37%

Stock Returns calculator for Immutep Ltd Stock including INR - Dollar returns

The Immutep Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immutep Ltd investment value today

Current value as on today

₹78,028

Returns

₹21,972

(-21.97%)

Returns from Immutep Ltd Stock

₹26,840 (-26.84%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Immutep Ltd Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Immutep Ltd. Average target price of $9.5

Immutep Ltd Share Price Target

Get share price movements and forecasts by analysts on Immutep Ltd.

What analysts predicted

82.21%UPSIDE

Target Price

$9.5

Current Price

$1.69

Analyzed by

9 Analysts

Target

$9.50

Immutep Ltd target price $9.5, a slight upside of 82.21% compared to current price of $1.69. According to 9 analysts rating.

Immutep Ltd Quarterly Profit & Loss

All numbers in Millions USD

Sep 2022
Dec 2022
Sep 2023
Dec 2023
Jun 2024
Sep 2024
Dec 2024
Total Revenue
0
1
1
2
1
1
3
Gross Profit
0
0
0
1
-19
-19
-22
Operating Income
-19
-23
-21
-25
-44
-44
-51
EBITDA
-18
-20
-19
-22
-22
-22
-26
Interest Expense
0
0
0
0
0
0
-
Depreciation
-
-
-
-
-
-
-
Income Before Tax
-15
-20
-19
-21
-21
-21
-22
Income Tax Expense
0
0
0
0
21
21
-
Net Income
-10
-13
-19
-21
-21
-21
-22
Net Profit Margin
-9356.52%
-1223.54%
-1058.85%
-1005.72%
-1241.29%
-1241.29%
-710.92%

Immutep Ltd Annual Profit & Loss

All numbers in Millions USD

Jun 2015
Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Total Revenue
1
0
3
1
0
5
3
0
2
2
Gross Profit
1
-5
1
-5
-11
-10
1
-1
0
-25
Operating Income
-13
-61
-9
-11
-20
-16
-19
-33
-44
-88
EBITDA
-13
-61
-8
-10
-18
-13
-17
-31
-39
-44
Interest Expense
18
0
-
-
-
0
0
0
0
0
Depreciation
-
-
1
1
1
2
2
2
-
-
Income Before Tax
-32
-63
-10
-12
-18
-13
-29
-32
-39
-42
Income Tax Expense
0
-1
0
0
-2
0
0
0
0
0
Net Income
-24
-45
-7
-9
-11
-9
-22
-22
-26
-28
Net Profit Margin
-1536.25%
-35426.72%
-221.89%
-484.55%
-11640.01%
-179.90%
-753.57%
-18906.51%
-1138.04%
-1111.87%

Immutep Ltd Quarterly Cash Flow

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Net Income
-9
-9
-19
-21
-
-21
-21
-22
-
Operating Cash Flow
-14
-8
-17
-17
-
-16
-17
-28
-
Investing Cash Flow
0
0
0
-10
-
-
-10
-62
-
Financing Cash Flow
0
76
38
47
0
95
95
0
0
Change in Cash
-13
68
68
103
-8
58
66
73
-

Immutep Ltd Annual Cash Flow

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Net Income
-62
-9
-12
-18
-13
-29
-32
-39
-42
Operating Cash Flow
-11
-8
-7
-15
-10
-17
-30
-35
-34
Investing Cash Flow
0
0
0
0
0
0
0
0
-21
Financing Cash Flow
25
0
18
8
20
52
50
76
95
Change in Cash
14
-8
11
-6
9
34
19
43
38

Global Institutional Holdings in Immutep Ltd

Funds
Holdings
BlackRock Inc
0.45%
Meridian Wealth Management, LLC
0.27%
XY Capital Ltd
0.09%
Steward Partners Investment Advisory, LLC
0.04%
Jane Street Group LLC
0.04%
See all

Insights on Immutep Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.73M → 3.14M (in $), with an average increase of 45.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, IMMP stock has moved up by 8.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 120.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 95.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 5 quarters, -19.27M → -22.37M (in $), with an average decrease of 3.9% per quarter

About Immutep Ltd

immutep is a globally active biotechnology company, listed on the australian stock exchange and on the nasdaq global market in the us. as a leader in personalized bio-therapeutic products for cancer, immutep is dedicated to leveraging its current technology and expertise to develop innovative treatment options for patients and maximize value to shareholders. immutep's main pipeline of products is based on the lag-3 immune control mechanism which plays a vital role in the regulation of the t cell immune response. the most clinically advanced product is a t cell immunostimulatory factor (apc activator), imp321, for cancer chemoimmunotherapy which has completed early phase ii trials. a number of additional lag-3 products including antibodies for immune response modulation in autoimmunity and cancer are being developed by large pharmaceutical partners.
OrganisationImmutep Ltd
HeadquartersAustralia Square, Sydney, NSW, Australia, 2000
IndustryHealth Technology
CEOMr. Marc Voigt
E-voting on sharesClick here to vote

Key Management of Immutep Ltd

Name

Title

Mr. Christian Mueller BBA, MSc.

Chief Development Officer

Mr. Stephan Winckels M.D., Ph.D.

Chief Medical Officer

Ms. Indira Naidu

Joint Company Secretary

Mr. Marc Voigt

CEO, MD, CFO, Chief Business Officer & Executive Director

Ms. Deanne Miller LLB

COO, General Counsel & Joint Company Secretary

Dr. Frederic Triebel M.D., Ph.D.

Chief Scientific Officer & Executive Director

FAQs

What is Immutep Ltd share price today?

Immutep Ltd share price today is $1.69 as on . Immutep Ltd share today touched a day high of $1.72 and a low of $1.68.

What is the 52 week high and 52 week low for Immutep Ltd share?

Immutep Ltd share touched a 52 week high of $2.71 on and a 52 week low of $1.32 on . Immutep Ltd stock price today i.e. is trending at $1.69,which is 37.64% down from its 52 week high and 28.03% up from its 52 week low.

What is Immutep Ltd's market capitalisation today?

Immutep Ltd market capitalisation is $0.00T as on .

How to invest in Immutep Ltd Stock (IMMP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immutep Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immutep Ltd Shares that will get you 0.8876 shares as per Immutep Ltd share price of $1.69 per share as on September 16, 2025 at 11:41 pm IST.

What is the minimum amount required to buy Immutep Ltd Stock (IMMP) from India?

Indian investors can start investing in Immutep Ltd (IMMP) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Immutep Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Immutep Ltd share’s latest price of $1.69 as on September 16, 2025 at 11:41 pm IST, you will get 5.9172 shares of Immutep Ltd. Learn more about fractional shares .

What are the returns that Immutep Ltd has given to Indian investors in the last 5 years?

Immutep Ltd stock has given 8.12% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?